Home / Products / Knockout Cell Lines

Knockout Cell Lines

Knockout cell lines provide defined loss-of-function models for studying gene activity in a controlled cellular background. By removing or disrupting a specific gene, researchers can directly evaluate its contribution to signaling pathways, disease phenotypes, drug sensitivity, cell growth, immune response, metabolism, differentiation, and other biological processes. As a key group of genome-edited cell lines, knockout cell lines are widely used in target validation, mechanism-of-action studies, functional screening, biomarker research, and disease model development.

Ascent Research offers CRISPR knockout cell lines across a range of commonly used mammalian cell line backgrounds. Our CRISPR KO cell line products are mainly generated using CRISPR RNP-based editing, in which Cas9 protein and guide RNA are delivered directly into cells. This non-viral strategy supports efficient gene disruption while avoiding unnecessary vector-based integration. Edited regions are typically confirmed by Sanger sequencing to verify the presence of target-site mutations and support reliable downstream use.

This category includes both clonal knockout cell lines and polyclonal KO cell pools. Clonal knockout cell lines are suitable when researchers require a more uniform genetic background and stable performance across repeated experiments. Polyclonal knockout cells, also called KO cell pools, provide a more economical option for early-stage screening, assay setup, pathway exploration, or projects where a mixed edited population is acceptable. These cell pools can help reduce cost and shorten project timelines before moving into single-cell clone selection.

In addition to standard knockout cell line products, Ascent Research supports custom cell line development for gene-specific knockout projects. Researchers can select host cell backgrounds based on disease relevance, pathway activity, assay compatibility, or comparison with parental and isogenic cell lines. Whether you need a knockout cell line for focused gene function research or multiple KO cell lines for broader screening applications, our engineered cell lines provide practical in vitro models for investigating gene loss and its biological consequences.

Showing 12 of 41685 results

VIRMA Knockout HCT 15 Cell Line

The VIRMA Knockout HCT 15 Cell Line is a CRISPR/Cas9-edited human colorectal adenocarcinoma cell line with targeted disruption of the VIRMA gene. VIRMA encodes a…
Cat. No. ARG44212

USP7 Knockout DU145 Cell Line

The USP7 Knockout DU145 Cell Line is a CRISPR/Cas9-edited human prostate carcinoma cell model with targeted disruption of USP7, a deubiquitinase that stabilizes MDM2 and…
Cat. No. ARG44211

USP7 Knockout HeLa Cell Line

The USP7 Knockout HeLa Cell Line is a CRISPR/Cas9-edited knockout cell line generated from HPV-18-positive human cervical adenocarcinoma HeLa cells. USP7 is a deubiquitinase that…
Cat. No. ARG44210

USP6NL Knockout Hela Cell Line

USP6NL Knockout Hela Cell Line provides a loss-of-function model for USP6NL, a GTPase-activating protein that inactivates RAB5 and RAB21 to regulate early endosome fusion and…
Cat. No. ARG44209

Ulk4 Knockout Neuro-2a Cell Line

The Ulk4 Knockout Neuro-2a Cell Line is a CRISPR/Cas9-edited knockout cell line derived from mouse neuroblastoma, targeting the Ulk4 gene. ULK4 is a serine/threonine kinase…
Cat. No. ARG44208

UGCG Knockout Vero Cell Line

The UGCG Knockout Vero Cell Line is a CRISPR/Cas9-edited knockout cell line derived from Vero kidney epithelial cells (Chlorocebus sabaeus), targeting the UGCG gene that…
Cat. No. ARG44207

UBXN4 Knockout DU145 Cell Line

The UBXN4 Knockout DU145 Cell Line is a CRISPR/Cas9-edited knockout cell line derived from the DU145 prostate carcinoma cell line, a model of androgen-independent prostate…
Cat. No. ARG44206

UBE2S Knockout Huh-7 Cell Line

The UBE2S Knockout Huh-7 Cell Line is a genetically engineered human hepatocellular carcinoma cell model with CRISPR/Cas9-mediated disruption of the UBE2S gene, encoding an E2…
Cat. No. ARG44205

TYR Knockout ARPE-19 Cell Line

The TYR Knockout ARPE-19 Cell Line is a CRISPR/Cas9-edited human retinal pigment epithelial cell model featuring targeted disruption of the tyrosinase (TYR) gene. This knockout…
Cat. No. ARG44204

TUBB4A Knockout DU145 Cell Line

The TUBB4A Knockout DU145 Cell Line is a CRISPR/Cas9-edited knockout model derived from androgen-independent prostate cancer cells, targeting the TUBB4A gene encoding tubulin beta-4A. This…
Cat. No. ARG44203

Tub Knockout Neuro-2a Cell Line

The Tub Knockout Neuro-2a Cell Line is a CRISPR/Cas9-edited knockout mouse neuroblastoma cell line that disrupts expression of the Tub gene, encoding the Tubby transcription…
Cat. No. ARG44202

TSPAN1 Knockout A549 Cell Line

The TSPAN1 Knockout A549 Cell Line is a CRISPR/Cas9-edited loss-of-function model derived from A549 human lung adenocarcinoma cells. TSPAN1, a tetraspanin, organizes integrin complexes such…
Cat. No. ARG44201

Loading products...